Evidence map›Paper›PMID 40698174›Full record

ArticleAccess microbiology2025

Protein profile of the Escherichia coli strain, BW25113, exposed to two novel iron-halide compounds: Fe(Hampy)2Cl4 and Fe(Hampy)2Br4.

Nusrat Abedin, Sarah Wagner, Yukta Sanjay Khalkar, Zulekha Johnson, Biola F Egbowon, Alan J Hargreaves, Anthony J Fitzpatrick, Amanda K Miles, Felix Dafhnis-Calas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Access microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nusrat AbedinSchool of Life Sciences, Faculty of Medicine and Health Science, University of Nottingham, Nottingham, NG7 2RD, UK.
Sarah WagnerJohn van Geest Cancer Research Centre, Nottingham Trent University, Nottingham NG11 8NS, UK.
Yukta Sanjay KhalkarSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.
Zulekha JohnsonSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.
Biola F EgbowonSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.
Alan J HargreavesSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.
Anthony J FitzpatrickSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.
Amanda K MilesJohn van Geest Cancer Research Centre, Nottingham Trent University, Nottingham NG11 8NS, UK.
Felix Dafhnis-CalasSchool of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.ORCID https://orcid.org/0000-0002-9275-2378

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mortality rate and economic burden of infections caused by antimicrobial-resistant pathogens are increasingly higher. This frustrating scenario emphasizes the urgent need for developing new antimicrobial drugs. We have previously addressed this problem by studying the antimicrobial activity of two novel iron-halide complexes, Fe(Hampy)

Indexed as

antibiotic resistanceantimicrobial compoundEscherichia colipathogensproteomics

Identifiers

PMID40698174
PMCPMC12282026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.